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S U M M A R Y
Background: Multidrug-resistant (MDR) Enterobacteriaceae can cause severe infections with high
morbidity, mortality, and health care costs. Individuals can be fecal carriers of these resistant organisms.
Data on the extent of MDR Enterobacteriaceae fecal carriage in the community setting in Lebanon are very
scarce. The aim of this study was to investigate the fecal carriage of MDR Enterobacteriaceae among the
elderly residents of two nursing homes located in north Lebanon.
Methods: Over a period of 4 months, ﬁve fecal swab samples were collected from each of 68 elderly
persons at regular intervals of 3–4 weeks. Fecal swabs were subcultured on selective media for the
screening of resistant organisms. The phenotypic detection of extended-spectrum beta-lactamase
(ESBL), AmpC, metallo-beta-lactamase (MBL), and Klebsiella pneumoniae carbapenemase (KPC)
production was performed using the beta-lactamase inhibitors ethylenediaminetetraacetic acid,
phenylboronic acid, and cloxacillin. A temocillin disk was used for OXA-48. Multiplex PCRs were used for
the genotypic detection of ESBL and carbapenemase genes, and sequencing was performed to identify
CTX-M-15. The medical records of each subject were reviewed on a regular basis in order to assess the
risk factors associated with MDR Enterobacteriaceae fecal carriage.
Results: Over the study period, 76.5% of the recruited elderly persons were at least one-time carriers. A
total of 178 isolates were obtained. Phenotypic testing revealed that 91.5% of them were ESBL producers,
4% were AmpC producers, 2.8% were co-producers of ESBL and AmpC, and 1.7% were co-producers of
OXA-48 and ESBL. Recent antibiotic intake was found to be the only independent risk factor associated
with the fecal carriage of MDR Enterobacteriaceae.
Conclusions: The high prevalence of MDR Enterobacteriaceae detected in this study and the emergence of
carbapenem resistance is alarming. Efﬁcient infection control measures and antibiotic stewardship
programs are urgently needed in these settings in order to limit the spread of resistant strains.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Multidrug-resistant (MDR) Enterobacteriaceae are currently
considered a major public health concern worldwide.1,2 They
can be transmitted easily among patients and healthy persons.3
Studies have shown that after being selected by antibiotics, the
cross-transmission of these organisms occurs frequently in the
health care setting.4 This dissemination will eventually lead to
increased rates of MDR Enterobacteriaceae carriage. This carriage is
often unrecognized and has been known to increase the risk of
contracting infections caused by resistant agents.5 The treatment* Corresponding author. Tel./fax: +961.6.930250 (ext. 3819).
E-mail address: ziad.daoud@balamand.edu.lb (Z. Daoud).
http://dx.doi.org/10.1016/j.ijid.2016.02.007
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).of these cases is often challenging due to the limited therapeutic
options; the antibiotic pipeline is drying up and no new
antimicrobial agents targeted against MDR Enterobacteriaceae
are foreseen in the near future.6
There is increasing evidence that nursing homes in the
community are important reservoirs for MDR Enterobacteria-
ceae.4,7 This is in major part due to the inappropriate use of
antimicrobial agents in these facilities,8 in addition to the
difﬁculties particularly faced when establishing antibiotic stew-
ardship and infection control programs.9,10 The prevalence of MDR
Enterobacteriaceae colonization in nursing homes varies according
to the geographical location, patient population, and the level of
care provided.10
In the Middle East, although several studies have been
conducted to assess the prevalence of MDR Enterobacteriaceae inciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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iaceae among nursing home residents in these countries are very
scarce. In Lebanon, clinical investigations have shown that the
prevalence of MDR Enterobacteriaceae is on a continuous rise.12
Local data reported in the form of ﬂyers summarizing the
susceptibility of bacteria at the Centre Hospitalier Du Nord in
the north of Lebanon, show that between 2011 and 2013 the rate of
extended-spectrum beta-lactamase (ESBL) production among
clinical isolates increased from 24.6% to 30.4% and from 26.5%
to 31.7% in Escherichia coli and Klebsiella pneumoniae, respectively
(Ziad Daoud). Another recent study reported an increase of 1.2% in
resistance and decreased susceptibility to ertapenem in clinical
isolates of Enterobacteriaceae. This resistance was mainly attribut-
ed to the production of OXA-48 beta-lactamase.12
In an attempt to understand the situation of carriage in the
nursing homes of the country and to shed light on this important
issue, the present research group conducted a study in Lebanon in
which it was found that 71.6% of the recruited elderly subjects
were at least one-time carriers during the study period.13 The plan
was to study the situation in the north of Lebanon, where the
extent of the spread of bacterial resistance in the community is not
well documented. The socio-cultural as well as economic and
educational levels in the north of Lebanon are also very particular
to this area of the country. These include the level of poverty and
the absence of basic governmental services such as public
sanitation and infrastructure, as most of the services are
concentrated in the capital Beirut. Unfortunately, all of these data
are anecdotal and based on impressions, since ofﬁcial statistics are
not available in the country.
The aim of this study was thus to investigate the fecal carriage
of MDR Enterobacteriaceae among the residents of two major
nursing homes located in the north of Lebanon through the
determination of the prevalence, dynamics, and risk factors for
MDR Enterobacteriaceae fecal carriage among elderly subjects. In
addition, it was sought to determine whether CTX-M-15, the
predominant ESBL gene in the Lebanese population,14 was also the
major ESBL genotype carried among these elderly people.
2. Materials and methods
2.1. Ethics, consent, and permissions
The Research Committee of the University of Balamand and the
Project Management Unit at the Lebanese Ministry of Agriculture
approved this study. The patient or his/her legal guardian or family
member signed a consent form for their participation in the study.
The privacy of participants and transparency of the ethical process
were guaranteed.
2.2. Study design and population
This was a cross-sectional study conducted in two major
nursing homes located in Tripoli in the north of Lebanon.
Candidates for this study were elderly residents aged >60 years.
A total of 68 individuals were recruited. Fifty-seven were chosen
randomly from nursing home 1. This facility has around 60 rooms
and a capacity of 200 beds. Eleven elderly persons were recruited
randomly from nursing home 2. This facility offers around
20 rooms with a capacity of 50 beds.
2.3. Data collection
The medical records of each elderly person were reviewed with
the help of the nurse responsible. Age, sex, number of roommates,
mobility status (ambulant/in a wheelchair or bedridden), and the
date of admission were all recorded. In addition, urinary/fecalincontinence, the presence of wounds or ulcers, and the previous or
current use of a urinary catheter were also reported. Furthermore,
the recruited elderly persons were checked for comorbidities (MDR
bacterial infections, diabetes, cancer, pulmonary, cardiovascular,
renal, or neurological diseases, and urogenital pathologies),
hospital admission during the last year, and whether they had
undergone any surgeries, as well as their antibiotic intake during
the last 3 months.
2.4. Collection of fecal swabs and isolation of resistant
Enterobacteriaceae
Between December 2013 and April 2014, ﬁve samples (fecal
swabs) were obtained from each of 68 elderly persons at regular
intervals of 3–4 weeks. A total of 262 samples were collected: 59 at
collection 1, 51 at collection 2, 57 at collection 3, 51 at collection 4,
and 44 at collection 5. The fecal swabs were subcultured on
MacConkey agar supplemented with cefotaxime (2 mg/ml) for the
screening of MDR Enterobacteriaceae. From each selective plate,
different colonies presenting with different morphologies were
picked up separately and suspended in Luria broth. After overnight
incubation, each bacterial suspension was subcultured again on a
selective plate. The following day, if the plate contained colonies
with single morphologies, the isolate was preserved in 20% glycerol
aliquots at 20 8C for further testing; if more than one type was
observed, a re-isolation was performed for further puriﬁcation.
An elderly subject was deﬁned as a carrier if an MDR
Enterobacteriaceae was isolated from his/her fecal sample. If the
patient was found to be a carrier at all ﬁve collections, he/she was
considered a ‘permanent carrier’. If the resistant bacterium was
isolated at fewer than ﬁve collections, the subject was deﬁned as an
‘intermittent carrier’. Finally, if no MDR Enterobacteriaceae was
isolated during the ﬁve collections, the subject was considered a
‘never carrier’. All isolates were identiﬁed using biochemical
gallery tests (API 20E; bioMe´rieux).
2.5. Phenotypic tests
Antimicrobial susceptibility testing was performed for 178 iso-
lates using the Kirby–Bauer disk diffusion method. Interpretation
of the results was performed in accordance with the Clinical and
Laboratory Standards Institute (CLSI) guidelines 2014.15 Fifteen
antimicrobial agents were tested (Table 1). The amoxicillin–
clavulanic acid disk was placed in the center between cefepime,
ceftazidime, and aztreonam, in order to detect a possible ‘keyhole
effect’. AmpC beta-lactamase and carbapenemase production was
suspected when resistance to cefoxitin and ertapenem, respec-
tively, was observed. Unfortunately, resistance to cefoxitin is not
sufﬁcient to distinguish between constitutive and plasmid-
mediated AmpC, therefore it was considered that both types of
AmpC were detected by this test. In order to conﬁrm these
phenotypically, ethylenediaminetetraacetic acid (EDTA), phenyl-
boronic acid (PBA), and cloxacillin were used as beta-lactamase
inhibitors.16–18 In addition, temocillin susceptibility testing was
performed as a presumptive test for the detection of the OXA-48
enzyme.19
2.6. Detection of ESBL type using multiplex PCR
In order to identify the type(s) of ESBL present in the clinical
isolates, multiplex PCR was performed on a representative sample
of 18 isolates chosen based on their proﬁle of resistance. Bacterial
DNA was prepared by suspending one or two colonies of each test
isolate in 200 ml of distilled water and heating the solution at 95 8C
for 10 min. The presence of blaCTX-M, blaSHV, blaTEM, and blaOXA
genes was tested using previously published primer sets and
Table 1
Rates of susceptibility of different Enterobacteriaceae isolates









Ampicillin 0 (0) 0 (0) 0 (0) 0 (0)
Aztreonam 7 (4.4) 0 (0) 2 (22.2) 1 (20)
Cefoxitin 138 (86.8) 5 (100) 8 (88.8) 4 (80)
Cefotaxime 0 (0) 0 (0) 0 (0) 0 (0)
Ceftazidime 16 (10) 0 (0) 1 (11.1) 0 (0)
Cefepime 9 (5.6) 0 (0) 0 (0) 0 (0)
Amoxicillin–clavulanic acid 61 (38.3) 2 (40) 1 (11.1) 3 (60)
Piperacillin–tazobactam 68 (42.7) 1 (20) 4 (44.4) 0 (0)
Meropenem 156 (98.1) 5 (100) 9 (100) 5 (100)
Imipenem 156 (98.1) 5 (100) 9 (100) 5 (100)
Ertapenem 156 (98.1) 5 (100) 9 (100) 5 (100)
Tigecycline 118 (100)a 3 (100)a 6 (100)a 5 (100)
Trimethoprim–sulfamethoxazole 59 (37.1) 0 (0) 1 (11.1) 0 (0)
Ciproﬂoxacin 65 (40.8) 1 (20) 2 (22.2) 0 (0)
Gentamicin 83 (52.2) 1 (20) 4 (44.4) 2 (40)
a Only 118 E. coli, three K. pneumoniae, and six K. oxytoca isolates were tested for tigecycline susceptibility.
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(Qiagen), 4 ml of primers, and 1 ml of DNA, and was made up to a
total volume of 20 ml with sterile distilled water. The PCR reaction
conditions consisted of a 15 min denaturation step at 95 8C,
followed by 30 ampliﬁcation cycles of 30 s at 94 8C, 90 s at 62 8C,
and 60 s at 72 8C, with a ﬁnal extension step of 10 min at 72 8C.20
The primer sequences and expected amplicon sizes of the target
ESBL genes were as follows: for blaSHV: F-CTTTATCGGCCCTCACTCAA,
R-AGGTGCTCATCATGGGAAAG (327 bp); blaTEM: F-CGCCGCATACAC-
TATTCTCAGAATGA, R-ACGCTCACCGGCTCCAGATTTAT (445 bp);
blaCTX-M: F-ATGTGCAGYACCAGTAARGTKATGGC, R-TGGGTRAAR-
TARGTSACCAGAAYCAGCGG (593 bp); blaOXA: F-ACACAATACATAT-
CAACTTCGC, R-AGTGTGTTTAGAATGGTGATC (813 bp).
In order to visualize the PCR amplicons, samples were mixed
with 4 ml of Thermo Scientiﬁc loading dye and loaded into the
wells of a 1.5% agarose gel in 1 Tris–acetate–EDTA (TAE) buffer.
The gel was run at 130 V for 60 min. Amplicons were visualized
using an ultraviolet transilluminator system (DIGI DOC-IT System)
for analysis. The gel had one well containing a DNA ladder (100 bp;
Thermo Scientiﬁc) in order to be able to estimate the size of the
DNA amplicons.
2.7. Plasmid sequencing and analysis
Plasmid DNA was extracted as described above, quantiﬁed
using Qubit, and sequenced using the Illumina NGS platform. The
sequence data were downloaded from the GenBank database and
each sequence ﬁle was compared to a number of reference plasmid
replicon sequences present in the Plasmid Finder database using
BLASTn. Circular representations of the plasmid sequence were
created using Unipro UGENE software, and the sequenced
plasmids were aligned and compared to reference replicon
sequences using BioEdit software.
2.8. Detection of carbapenemase genes using PCR
Another multiplex PCR was conducted for the detection of the
carbapenem resistance genes Klebsiella pneumoniae carbapene-
mase (KPC), New Delhi metallo-beta-lactamase (NDM), OXA-48,
IMP, SPM, and VIM. DNA extraction was performed as described in
the previous section. The presence of the carbapenem resistance
genes was tested using universal primers.21 PCR ampliﬁcation
reactions were performed in a volume of 20 ml containing 10 ml of
Taq PCR Master Mix, 5 ml of sterile water, 4 ml of the primer mix,
and 1 ml of the extracted DNA. The conditions of the PCR reactionwere as follow: 94 8C for 10 min, then 36 cycles of 30 s at 94 8C, 40 s at
52 8C,and50sat72 8Cforampliﬁcation,then5 minat72 8Cfortheﬁnal
extension.21 Ampliﬁed DNA products were subjected to electro-
phoresisona1.5%agarosegel in1 TAEbuffer.Thegelwasrunat130 V
for 1 h. The visualization of amplicons was performed using an
ultraviolet transilluminator system (DIGI DOC-IT System) for analysis.
The primer sequences and expected amplicon sizes of
target carbapenemase genes were as follows: blaKPC: F-
CGTCTAGTTCTGCTGTCTTG, R-CTTGTCATCCTTGTTAGGCG (798 bp);
blaNDM: F-GGTTTGGCGATCTGGTTTTC, R-CGGAATGGCTCATCACGATC
(621 bp); blaOXA-48: F-GCGTGGTTAAGGATGAACAC, R-CATCAAGTT-
CAACCCAACCG (438 bp); blaIMP: F-GGAATAGAGTGGCTTAAYTCTC,
R-GGTTTAAYAAAACAACCACC (232 bp); blaSPM: F-AAAATCTGGG-
TACGCAAACG, R-ACATTATCCGCTGGAACAGG (271 bp); blaVIM: F-
GATGGTGTTTGGTCGCATA, R-CGAATGCGCAGCACCAG (390 bp).
2.9. Statistics and data analysis
For univariate analysis, classical descriptive methods were used
according to each site separately. Furthermore, the distributions of
variables according to carriage status were compared by conduct-
ing a bivariate analysis. A p-value of 0.05 was considered
statistically signiﬁcant. Furthermore, risk factors with a p-value of
0.15 were subjected to multivariate analysis. IBM SPSS Statistics
version 20.0 (IBM Corp., Armonk, NY, USA) was used for all
statistical calculations.
3. Results
3.1. Demographics and prevalence of MDR Enterobacteriaceae fecal
carriage
The demographic characteristics of the elderly subjects are
presented in Table 2. For both nursing homes, the prevalence of
fecal carriage was as follow: 32 elderly subjects (54.2%) were fecal
carriers at the ﬁrst collection, 33 (64.7%) at the second collection,
24 (42.1%) at the third collection, 24 (47%) at the fourth collection,
and 25 (56.8%) at the ﬁfth collection. Overall, 76.5% of the recruited
residents were at least one-time carriers, while 23.5% of them were
never carriers.
3.2. Dynamics of MDR Enterobacteriaceae fecal carriage
In this study, 262 samples were collected, of which 138
were positive for MDR Enterobacteriaceae (52.6%). From these
Table 2
Characteristics of nursing home residents recruited in this studya
NH1 NH2
Total number 57 11
Sex
Male 19 (33.3) 5 (45.5)
Female 38 (66.7) 6 (54.5)
Age, years, mean (SD) 78 (7.8) 75.82 (9.3)
LOS, days, mean (median) 1016 (818) 402.36 (598)
Room accommodation
Single 3 (5.3) 10 (90.9)
Double 13 (22.8) 1 (9.1)
Triple 1 (1.8) 0 (0)
Quadruple 4 (7) 0 (0)
More than 4 beds/room 36 (63.2) 0 (0)
Mobility status
Ambulant 11 (19.3) 4 (36.4)
Wheelchair 46 (80.7) 4 (36.4)
Bedridden 0 (0) 3 (27.3)
Urinary catheter 4 (7) 4 (36)
Urinary/fecal incontinence 43 (75.4) 7 (63.6)
Wounds/ulcers 6 (10.5) 2 (18.2)
Recent surgery during last 3 months 2 (3.5) 3 (27.3)
Recent hospitalization during last year 8 (14) 4 (36.4)
Recent antibiotic intake during
last 3 months
27 (47.4) 7 (63.6)
Multidrug-resistant bacterial infections 2 (3.5) 0 (0)
Diabetes 6 (10.5) 4 (36.4)
Cancer 2 (3.5) 0 (0)
Pulmonary diseases 6 (10.5) 3 (27.3)
Cardiovascular diseases 24 (42.1) 4 (36.4)
Neurological diseases 24 (42.1) 2 (18.2)
Urogenital pathologies 11 (19.3) 4 (36.4)
Renal diseases 1 (1.8) 0 (0)
NH, nursing home; SD, standard deviation; LOS, length of stay.
a All data are presented as the number (%) unless stated otherwise.
Table 3
Rates of susceptibility of MDR Enterobacteriaceae isolates








I. Dandachi et al. / International Journal of Infectious Diseases 45 (2016) 24–31 27138 positive samples, 178 isolates were obtained. The number of
elderly subjects versus the number of isolates was not 1 to 1, since
more than one isolate was obtained for some residents. Overall,
159 isolates (89%) were identiﬁed as E. coli, 14 (8%) as Klebsiella spp,
and ﬁve (3%) as Citrobacter spp.
The fecal carriage among elderly subjects varied from one
collection to another (Figure 1). From collection 1 to 2, the carriage
of MDR Enterobacteriaceae disappeared for four subjects (12.5%),
while it appeared in 10 (37%). Between collections 2 and 3, the
carriage disappeared in 13 subjects (38.2%), while it appeared in
two (11.8%). Between collections 3 and 4, six carriers (25%) became
non-carriers, while eight non-carriers (24.2%) became carriers.
Between collections 4 and 5, the carriage disappeared in six
subjects (25%), while it appeared in 10 (37%). Overall, out of
the 52 elderly subjects who were at least one-time carriers,
eight (15.4%) were permanent carriers, while 44 (84.6%) wereFigure 1. Dynamics and stability of multidrug-resistant Enterobacteriaceae fecal
carriage.intermittent carriers. E. coli was the most stable resistant colonizer
isolated at the ﬁve collections, while Klebsiella spp and Citrobacter
spp were only isolated at four and three of the collections,
respectively.
3.3. ESBL, AmpC, and OXA-48 detection
The antimicrobial susceptibility testing results are summarized
in Table 3. Phenotypic testing revealed that out of 178 isolates, 163
(91.5%) were ESBL producers. Five isolates (2.8%) were found to be
co-producers of ESBL and AmpC. Seven isolates (4%) were
considered AmpC producers. Furthermore, 46% of the isolated
ESBL and/or AmpC producers were co-resistant to at least two
other non-beta-lactam antimicrobial agents, 38% were co-resistant
to only one non-beta-lactam, and 16% showed no co-resistance.
The detailed susceptibility rates for each category are presented in
Table 3. As an average of the ﬁve collections, 89.5% of ESBL
production was detected in E. coli, while only 8.5% and 1.8% were
detected in Klebsiella spp and Citrobacter spp, respectively. A 71.4%
AmpC production was observed in E. coli; however, the methodol-
ogy used does not distinguish between the constitutive and
plasmid-mediated resistance due to AmpC. The simultaneous
production of ESBL and AmpC, as well as ESBL and OXA-48, was
observed at only the ﬁrst and second collections; in both cases
these were produced by isolates of E. coli (Table 4). Three isolates of
E. coli were carbapenem-non-susceptible. Two of these were
isolated from the same patient during the ﬁrst and second
collections, while the third was isolated from another patient
during the ﬁrst collection. In the subsequent collections, no
carbapenem-resistant isolates were detected. Phenotypic tests
suggested an OXA-48 probably co-produced with ESBL. In this
regard, temocillin disks were used for the three isolates (Figure 2).
3.4. Genotypic detection of resistance and occurrence of CTX-M-15
Multiplex PCR analysis performed on 18 isolates revealed the
presence of the TEM gene in 17 of them, CTX-M in 16, OXA in four,
and SHV in two. Eleven isolates showed coexistence of CTX-M and
TEM genes, four showed coexistence of three or four genes, and
three isolates harbored only one gene (Figure 3). The 16 isolates
harboring the CTX-M gene were all positive for CTX-M-15 afterAmpicillin 0 (0) 0 (0) 0 (0)
Aztreonam 7 (4.2) 0 (0) 3 (42.8)
Cefoxitin 152 (93.2) 0 (0) 0 (0)
Cefotaxime 0 (0) 0 (0) 0 (0)
Ceftazidime 14 (8.5) 0 (0) 0 (0)
Cefepime 2 (1.2) 0 (0) 7 (100)
Amoxicillin–
clavulanic acid
67 (41.1) 0 (0) 0 (0)
Piperacillin–tazobactam 68 (41.7) 2 (40) 3 (42.8)
Meropenem 163 (100) 5 (100) 7 (100)
Imipenem 163 (100) 5 (100) 7 (100)
Ertapenem 163 (100) 5 (100) 7 (100)
Tigecycline 122 (100)a 3 (100)a 7 (100)
Trimethoprim–
sulfamethoxazole
55 (33.74) 3 (60) 2 (28.5)
Ciproﬂoxacin 61 (37.4) 2 (40) 2 (28.5)
Gentamicin 83 (50.9) 1 (20) 6 (85.7)
MDR, multidrug-resistant; ESBL, extended-spectrum beta-lactamase.
a Only 122 ESBL producers and three ESBL and AmpC co-producers were tested
for tigecycline susceptibility.
Table 4










Klebsiella oxytoca 5 ESBL




Klebsiella oxytoca 3 ESBL
Klebsiella pneumoniae 3 ESBL
Collection 3 Escherichia coli 25 ESBL
1 AmpC
Citrobacter diversus 1 ESBL
Collection 4 Escherichia coli 26 ESBL
1 AmpC
Klebsiella pneumoniae 1 ESBL
Citrobacter diversus 1 ESBL
Collection 5 Escherichia coli 24 ESBL
1 AmpC
Klebsiella oxytoca 1 AmpC
Klebsiella pneumoniae 1 ESBL
Citrobacter diversus 2 ESBL
1 AmpC
MDR, multidrug-resistant; ESBL, extended-spectrum beta-lactamase.
Figure 2. Temocillin test for the phenotypic detection of OXA-48 production. (A) Nega
(resistance) with the three carbapenem-resistant Enterobacteriaceae isolates producing
Figure 3. Detection of the beta-lactamase genes SHV, TEM, CTX-M, and OXA in multidru
multiplex PCR. Lanes 1–18 represent the multidrug-resistant Enterobacteriaceae isolates 
DNA ladder. The molecular size of the band in question is indicated in parentheses on
I. Dandachi et al. / International Journal of Infectious Diseases 45 (2016) 24–3128DNA extraction and sequencing, therefore showing a high
occurrence of this enzyme in the ESBL population. In the
phenotypic testing, 17 out of the 18 isolates showed a keyhole
effect and were therefore identiﬁed as ESBL producers (Table 5).
Regarding the three carbapenem-resistant isolates, multiplex
PCR analysis showed that all of them harbored an OXA-48 gene
(Figure 4), thereby conﬁrming the phenotypic results.
In view of the low number of isolates selected for genotypic
testing, these results cannot be generalized, and tests addressing a
larger number of isolates should be performed in the future to
conﬁrm that this is true on a larger scale.
3.5. Risk factors associated with fecal carriage of MDR
Enterobacteriaceae
The associations between MDR Enterobacteriaceae fecal carriage
and different factors are presented in Table 6. Univariate analysis
revealed that recent antibiotic intake during the last 3 months and
urogenital pathologies were the only risk factors associated with
the fecal carriage of MDR Enterobacteriaceae (p = 0.03 and
p = 0.015, respectively). The percentage of residents who had a
recent antibiotic intake was 59.6% (31/52) among the at least one-
time carriers and 18.8% (3/16) among the never carriers. For
urogenital pathologies, the prevalence was 28.8% (15/52) in
carriers versus 0% (0/16) in never carriers. In the multivariate
analysis, three factors were included: recent antibiotic intake
(p = 0.03), urogenital pathologies (p = 0.015), and diabetes
(p = 0.102). This ﬁnal analysis revealed that recent antibiotictive results (sensitivity) with non-OXA-48 producing isolates. (B) Positive results
 OXA-48 isolated in this study.
g-resistant Enterobacteriaceae isolates obtained from nursing home residents, using
tested. Lane 19 corresponds to the positive control (TEM 455 bp). Lane M is a 1.2-kb
 the right of the image.
Table 5







Escherichia coli 10 ESBL TEM, CTX-M
Escherichia coli 2 ESBL TEM, CTX-M,OXA
Escherichia coli 2 ESBL TEM
Escherichia coli 1 ESBL CTX-M
Citrobacter diversus 2 ESBL TEM, SHV, CTX-M, OXA
Citrobacter diversus 1 AmpC TEM, CTX-M
ESBL, extended-spectrum beta-lactamase.
Figure 4. Detection of carbapenemase genes OXA-48, NDM, and KPC in
carbapenem-resistant Enterobacteriaceae isolates obtained from nursing home
residents, using multiplex PCR. Lanes 1–3 represent the carbapenem-resistant
Enterobacteriaceae isolates. Lane 4 corresponds to the negative control. Lane M is a
1.2-kb DNA ladder. The molecular size of the band in question is indicated in
parentheses on the right of the image.
Table 6




Total number 52 (76.5) 16 (23.5)
Sex
Male 19 (36.5) 5 (31.2)
Female 33 (63.5) 11 (68.8)
Age, years, mean (SD) 77.81 (7.7) 77.63 (9.3)
LOS, days, mean (median) 900.7 (610) 1629 (829.5)
Room accommodation
Single/double 22 (42.3) 5 (31.2)
Triple and more 30 (57.7) 11 (68.8)
Mobility status
Ambulant 12 (23) 3 (18.8)
Wheelchair/bedridden 40 (77) 13 (81.2)
Urinary catheter 7 (13.5) 1 (6.2)
Urinary/fecal incontinence 37 (71.2) 13 (81.2)
Wounds/ulcers 7 (13.5) 1 (6.2)
Recent surgery during last 3 months 5 (9.6) 0 (0)
Recent hospitalization during last year 11 (21) 1 (6.2)
Recent antibiotic intake during
last 3 months
31 (59.6)b 3 (18.8)b
Multidrug-resistant bacterial infections 2 (3.8) 0 (0)
Diabetes 10 (19.2)c 0 (0)c
Cancer 2 (3.8) 0 (0)
Pulmonary diseases 7 (13.5) 2 (12.5)
Cardiovascular diseases 23 (44.2) 5 (312)
Neurological diseases 19 (36.5) 7 (43.8)
Urogenital pathologies 15 (28.8)b 0 (0)b
Renal diseases 1 (1.9) 0 (0)
MDR, multidrug-resistant; SD, standard deviation; LOS, length of stay.
a All data are presented as the number (%) unless stated otherwise.
b p-Value 0.05.
c p-Value 0.15.
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Enterobacteriaceae fecal carriage.
4. Discussion
Although several studies have addressed the issue of MDR
Enterobacteriaceae in Lebanon, data on the spread of bacterial
resistance in the community are very scarce. Only one recent study
has been carried out in nursing homes in Beirut, and that study was
performed by the present research group. In that study, it was
found that 71.6% of the recruited elderly subjects were at least one-
time carriers.13 Similar results were found in the present study
implemented in the north of Lebanon (76.5%). These results,
however, are relatively high when compared to those from similar
studies conducted in long-term care facilities worldwide: 70.3% in
Italy,22 41.3% in Japan,23 and 14.7% in Australia.24 Differences in
sample size, medical care, and hand hygiene practices at each site,
in addition to differences in the microbiological screening methods
used in each study might have inﬂuenced the results and therefore
have yielded some variations.25 Another important factor to
consider when comparing these results is that the majority of the
studies were conducted at one time-point only.
As shown in the present study, the carriage status of an elderly
person should not be assumed on the basis of only one fecal
sampling; rather, multiple screening samples are needed. Accord-
ing to Filius et al., differences in colonization rates could arise as a
result of antibiotic consumption that has decreased the number of
MDR Enterobacteriaceae to an undetectable level in the stool
sample.26The fecal carriage of AmpC producers among the recruited
residents is an important ﬁnding in this study. AmpC-producing
Enterobacteriaceae strains have previously been reported in clinical
samples from Lebanon.27,28 However, the present study appears to
be the ﬁrst to report the prevalence of these MDR bacteria in a
community setting. AmpC beta-lactamases are cephalosporinases
that can be chromosomally mediated with inducible expression or
plasmid-mediated with constitutive expression.29,30 Along with
ESBLs, the non-recognition of these mechanisms by clinical
laboratory personnel leads to inappropriate reporting of the
antibiogram to the physician responsible. This in many cases may
lead to therapeutic failures.31 Nevertheless, the present study
might have suffered some limitations due to the use of phenotypic
tests to incriminate the corresponding mechanisms of resistance.
As is well known, these tests are very helpful for clinical
microbiology laboratories; however, their speciﬁcities and sensi-
tivities are questionable.
The detection of OXA-48 producers is a major and alarming
issue. These beta-lactamases are plasmid-mediated class D
oxacillinases that convey resistance to penicillins and have
moderate hydrolyzing activity to carbapenems.32 In this study,
the phenotypic conﬁrmation of OXA-48 production was performed
using temocillin disks. High-level resistance to temocillin is not
restricted to OXA-48 producers; metallo-beta-lactamases (MBLs)
and KPCs can also be highly resistant to temocillin.33 Therefore,
temocillin resistance is considered a phenotypic conﬁrmation of
OXA-48 only in cases where other carbapenem resistance
mechanisms are excluded.34 It is important to note that the three
ertapenem-resistant isolates in this study were intermediate to
meropenem and imipenem and were isolated from two different
elderly subjects who had no history of recent hospitalization;
however, recent antibiotic treatment with amoxicillin–clavulanic
acid was reported for one of them.
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economic and cultural differences between Beirut and Tripoli, the
results of this study were, to a certain extent, similar to those
obtained in the study previously undertaken by this research group
in Beirut.13 In this context, there is agreement between these two
studies on the frequency of carriage of ESBL-producing organisms
(E. coli 82.7% in Beirut and 89% in Tripoli, K. pneumoniae 9.7% in
Beirut and 8% in Tripoli). In addition, 80.7% of elderly subjects in
Beirut were at least one-time carriers and 19.3% never carriers,
while these percentages were found to be 76.5% and 23.5%,
respectively, in elderly persons in Tripoli. However, although both
studies agree that recent antibiotic intake is a signiﬁcant risk
factor, it was found that recent urinary tract pathologies and
diabetes were risk factors only among Tripoli nursing homes
residents. In addition, carbapenem-resistant Enterobacteriaceae
were not isolated from the Beirut population.
Obviously other factors played a role in this relatively high
prevalence. One possibility is the cross-transmission with resistant
bacteria, since 38.5% of elderly subjects who were at least a one-
time carrier had no history of recent antibiotic intake. In nursing
homes, modes of transmission of MDR Enterobacteriaceae usually
result from non-adherence to infection control measures; envi-
ronmental surfaces are not frequently decontaminated, waste is
often disposed of incorrectly, and hand hygiene practices are far
from optimal in these settings.10 In 2011, a randomized controlled
trial was undertaken in Hong Kong long-term care facilities in
order to determine the effectiveness of a hand hygiene infection
control program. During the study period, adherence to hand
hygiene increased signiﬁcantly and the occurrence of serious
infections decreased from 1.42 cases to 0.65 cases per 1000 resi-
dent-days.35
In conclusion, this study demonstrated that the prevalence of
fecal carriage of MDR Enterobacteriaceae in north Lebanon is high
and shows different patterns (one-time carriage, constant carriage,
never carriage, etc.). The screening of newly admitted residents for
the fecal carriage of MDR Enterobacteriaceae becomes a crucial
task. The emergence of carbapenem resistance in the community is
alarming; training of clinical laboratory technologists on the
appropriate detection of the different mechanisms of resistance is
essential. The prevalence of MDR Enterobacteriaceae fecal carriage
among elderly nursing home residents (76.5%) is noteworthy and
underlines the importance of nursing homes as reservoirs of
resistance in the Lebanese community. The fecal carriage of MDR
Enterobacteriaceae is dynamic and changes with time. In the
majority of the isolates obtained, multidrug resistance was
mediated by ESBL production. CTX-M-15 was present in 16 out
of the 18 tested ESBL-producing isolates. This does not differ from
the average CTX-M-15 in the Lebanese population, although the
number of genotypically tested isolates in this study was relatively
low. It is well known that phenotypic tests are not as accurate as
genotypic methods; however, these are the best available way to
detect resistance and incriminate the corresponding mechanism of
resistance with an acceptable level of certainty in the clinical
laboratories of the country.
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